Facilitating Drug Discovery in Breast Cancer by Virtually Screening Patients Using In Vitro Drug Response Modeling.

In particular, AZD-1775 response formed a highly significant (FDR = 5.6 × 10 −46 ) association with TP53 mutational status in breast cancer patients ( Figure 2 B).

also in 132,142 other papers